- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech Sustainable Track Record
Taiwanese Pharmaceuticals & Biotech Sustainable Track Record
Results
4
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
4 companies
PharmaEngine
Market Cap: NT$9.8b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$68.00
7D
-4.4%
1Y
-34.0%
TTY Biopharm
Market Cap: NT$19.7b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$79.30
7D
-0.3%
1Y
8.2%
Lotus Pharmaceutical
Market Cap: NT$73.4b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$279.00
7D
-5.6%
1Y
-2.1%
Bora Pharmaceuticals
Market Cap: NT$77.2b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$622.00
7D
0.2%
1Y
-0.6%